Mineral salts in urological applications
Phosphate binders for the treatment of hyperphosphatemia
Hyperphosphatemia is a disturbance in which there is an abnormally
elevated level of phosphate in the blood. This can be caused by
- Increased phosphate intake
- Increased phosphate release via body´s own tissue
- Lowered phosphate precipitation in renal failure
- Increased phosphate reabsorption by the kidneys.
If the phosphate level rises in serum this may lead on one hand to the concretion of calcium phosphate in blood and tissue and on the other hand, through binding phosphate with calcium, this could decrease dramatically the calcium level in serum causing a hypercalcaemia.
While an acute hyperphosphatemia requires an immediate and special treatment, a chronic hyperphosphatemia can be treated with phosphate binders.
In most treatments the following minerals are used:
- Calcium Acetate
- Calcium Carbonate
- Calcium Citrate
- Aluminium Hydroxide
- Aluminium Carbonate
We offer these products in different pharmaceutical qualities.
Disclaimer: The information given in the document corresponds to our current knowledge. We warrant in the frame of our General Terms and Conditions of Sale that our products are manufactured in accordance with the specifications. However, we disclaim any liability with regard to the suitability of our products for a particular purpose or application or their compatibility with other substances. Tests have to be performed by the customer who also bears the risk in this respect. Nothing herein shall be construed as a recommendation to use our products in conflict with third parties' rights.
